• 1. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 2. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 3. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 4. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 5. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554

Introduction to 3-tert-butylbicyclo[1.1.1]pentane-1-carboxylic acid (CAS No: 132663-73-1)

3-tert-butylbicyclo[1.1.1]pentane-1-carboxylic acid, identified by the chemical compound identifier CAS No: 132663-73-1, is a structurally intriguing molecule that has garnered significant attention in the field of organic chemistry and pharmaceutical research. This bicyclic compound features a tert-butyl substituent on a bicyclo[1.1.1]pentane scaffold, which imparts unique steric and electronic properties that make it a valuable building block for synthetic applications and drug discovery.

The molecular structure of 3-tert-butylbicyclo[1.1.1]pentane-1-carboxylic acid consists of a rigid three-membered cyclopropane ring fused to two six-membered carbocycles, creating a highly strained system. The presence of the tert-butyl group at the 3-position enhances the molecule's stability while simultaneously influencing its reactivity and interactions with biological targets. This structural motif has been explored in various contexts, including the development of novel ligands for enzyme inhibition and the synthesis of complex natural products.

In recent years, the pharmaceutical industry has shown increasing interest in bicyclic compounds due to their potential to exhibit improved pharmacokinetic properties, such as enhanced solubility and metabolic stability. The bicyclo[1.1.1]pentane core is particularly noteworthy for its ability to mimic certain rigid conformations found in biologically active molecules, making it a versatile scaffold for medicinal chemistry applications. The carboxylic acid functionality at the 1-position further expands its utility, allowing for facile derivatization into esters, amides, and other pharmacologically relevant derivatives.

One of the most compelling aspects of 3-tert-butylbicyclo[1.1.1]pentane-1-carboxylic acid is its role as a precursor in the synthesis of more complex molecules. Researchers have leveraged this compound to develop novel inhibitors targeting enzymes involved in cancer metabolism and inflammation pathways. For instance, studies have demonstrated that derivatives of this scaffold can interact with specific binding pockets on enzymes such as cyclooxygenase (COX) and lipoxygenase (LOX), which are key players in the inflammatory response.

The tert-butyl group in particular plays a critical role in modulating the electronic properties of the molecule, influencing both its reactivity and its interactions with biological targets. This substituent can also serve as a handle for further functionalization, enabling chemists to tailor the properties of derived compounds for specific applications. In addition, the strained nature of the bicyclo[1.1.1]pentane ring system can lead to unique conformational preferences, which can be exploited to design molecules with optimized binding affinities.

Recent advances in computational chemistry have further enhanced our understanding of how 3-tert-butylbicyclo[1.1.1]pentane-1-carboxylic acid behaves in biological systems. Molecular modeling studies have revealed that this compound can adopt multiple conformations depending on its environment, which may explain its broad spectrum of interactions with biological targets. These insights have guided the design of next-generation derivatives with improved pharmacological profiles.

The synthesis of 3-tert-butylbicyclo[1.1.1]pentane-1-carboxylic acid itself represents a significant challenge due to the inherent strain of the bicyclic system and the sensitivity of the tert-butyl group to harsh reaction conditions. However, recent methodologies have demonstrated that this compound can be accessed through multi-step synthetic routes involving cyclization reactions and selective functionalization strategies. These advancements have made it more feasible to explore its potential in drug discovery and material science applications.

Moreover, the versatility of 3-tert-butylbicyclo[1.1.1]pentane-1-carboxylic acid extends beyond pharmaceuticals into other areas such as agrochemicals and specialty chemicals. Its unique structural features make it an attractive candidate for developing novel pesticides and fragrances with improved efficacy and environmental compatibility.

In conclusion, 3-tert-butylbicyclo[1.1.1]pentane-1-carboxylic acid (CAS No: 132663-73-1) is a structurally fascinating molecule with significant potential in multiple domains of chemistry and biology. Its rigid bicyclic core combined with the electron-donating effects of the tert-butyl group provides a rich framework for synthetic exploration and pharmacological innovation.

• 75017-13-9(1,2,2-trimethylcyclobutane-1-carboxylic acid)
• 100231-70-7(Copper,(2-ethylhexanoato-O)(neodecanoato-O)- (9CI))
• 34970-18-8(3,3-dimethylcyclobutane-1-carboxylic acid)
• 32276-75-8(Octanoic acid,2,2-dimethyl-, copper(2+) salt (2:1))
• 3057-91-8(Spiro[3.3]heptane-2,6-dicarboxylic acid)
• 473-69-8(2,2-dimethylcyclobutane-1,3-dicarboxylic acid)
• 62194-58-5(Butanoic acid, 2,2-diethyl-, copper(2+) salt (2:1))
• 100231-69-4(Copper,(tert-decanoato-O)(2-ethylhexanoato-O)- (9CI))
• 406947-35-1(3-formylbicyclo[1.1.1]pentane-1-carboxylic acid)
• 28664-02-0(Pinic Acid (Diastereomeric Mixture))